α-Globin as a molecular target in the treatment of β-thalassemia
about
Customizing the genome as therapy for the β-hemoglobinopathiesMolecular nature of alpha-globin genes in the Saudi populationEnhancement of β-Globin Gene Expression in Thalassemic IVS2-654 Induced Pluripotent Stem Cell-Derived Erythroid Cells by Modified U7 snRNA.Combination of a triple alpha-globin gene with beta-thalassemia in a gypsy family: importance of the genetic testing in the diagnosis and search for a donor for bone marrow transplantation for one of their children.HbE/β-Thalassemia and Oxidative Stress: The Key to Pathophysiological Mechanisms and Novel Therapeutics.Oxidative instability of hemoglobin E (β26 Glu→Lys) is increased in the presence of free α subunits and reversed by α-hemoglobin stabilizing protein (AHSP): Relevance to HbE/β-thalassemia.Quality of life, clinical effectiveness, and satisfaction in patients with beta thalassemia major and sickle cell anemia receiving deferasirox chelation therapy.Advances in understanding erythropoiesis: evolving perspectivesCopy number variations of six and seven α-globin genes in a family with intermedia and major thalassemia phenotypes.Understanding α-globin gene regulation and implications for the treatment of β-thalassemia.Thalassemia: a look to the future.Emerging cellular and gene therapies for congenital anemias.Editing an α-globin enhancer in primary human hematopoietic stem cells as a treatment for β-thalassemiaSelective silencing of α-globin by the histone demethylase inhibitor IOX1: a potentially new pathway for treatment of β-thalassemia.Investigation of FoxO3 dynamics during erythroblast development in β-thalassemia major.Impact of annotation error in α-globin genes on molecular diagnosis.A Genetic Variant Ameliorates β-Thalassemia Severity by Epigenetic-Mediated Elevation of Human Fetal Hemoglobin Expression.The Frequency and Importance of Common α-globin Gene Deletions Among β-Thalassemia Carriers in an Iranian Population.Red blood cells free α-haemoglobin pool: a biomarker to monitor the β-thalassemia intermedia variability. The ALPHAPOOL study.Depression, Anxiety, and Perceived Social Support among Adults with Beta-Thalassemia Major: Cross-Sectional Study.Body iron status of children and adolescents with transfusion dependent β-thalassaemia: trends of serum ferritin and associations of optimal body iron control
P2860
Q26751061-959E7ADE-B545-4624-8039-32F3BF2F1E98Q28080626-71368CBF-6749-4981-99FA-EF3B063CBD0AQ33722582-F63F0A7C-E7EE-4DB0-AE7D-BB03AFC84933Q35990407-7EE49D1E-E9C4-44AB-9542-6AFB20E25D2DQ36138738-243D49D9-2816-4852-90C3-E20731D2730CQ36719908-66D1D0BF-49EF-48B6-B403-428F2B121F09Q36719941-7B1E8AE4-BA56-4247-ABE3-3234C8CDCB10Q36803829-E2ACABA7-4725-4D1D-AE7A-685B050E3A07Q38581835-F564AE06-8868-4E8B-91A0-22148B258214Q38676718-F58DB80F-AC3E-416D-9FB6-4A659EBC7DC4Q38729328-DAF7332A-1B35-4AAD-8350-02C3703B919BQ38993825-A8F5B06E-D496-44F0-AF85-21C000559A99Q41606454-1C748A0F-FE2A-4182-B873-0203B11AD1BEQ42361973-FAA6AAC7-80BA-4C99-8A5F-AB792D75B05BQ46264158-C56185F1-ED0F-49A4-9FF7-43670D4EAE0DQ46852492-D574BCA9-274B-4507-BA21-14850BEA89FDQ47129520-DA7C8663-9D69-4A18-92C6-5647F83ECC2FQ47139024-DD8F901A-7CA1-4444-9B55-5628035672C8Q48232409-D9038554-24B1-47EB-8A5E-004F45DDC3FFQ55082196-56121B47-31A7-4C0E-BD97-39957BF69920Q58803893-CE1B3E8E-7F99-4050-A670-772A703D7933
P2860
α-Globin as a molecular target in the treatment of β-thalassemia
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
α-Globin as a molecular target in the treatment of β-thalassemia
@ast
α-Globin as a molecular target in the treatment of β-thalassemia
@en
type
label
α-Globin as a molecular target in the treatment of β-thalassemia
@ast
α-Globin as a molecular target in the treatment of β-thalassemia
@en
prefLabel
α-Globin as a molecular target in the treatment of β-thalassemia
@ast
α-Globin as a molecular target in the treatment of β-thalassemia
@en
P2860
P1433
P1476
α-Globin as a molecular target in the treatment of β-thalassemia
@en
P2093
Richard J Gibbons
P2860
P304
P356
10.1182/BLOOD-2015-03-633594
P407
P577
2015-04-13T00:00:00Z